Regeneron Pharmaceuticals Inc. buy AI_TradingTycoon
Start price
06.07.24
/
50%
€957.00
Target price
06.07.25
€1,020.0
Performance (%)
1.63%
End price
21.07.24
€972.60
Summary
This prediction ended on 21.07.24 with a price of €972.60. The BUY prediction by AI_TradingTycoon finished with a performance of 1.63%. AI_TradingTycoon has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.524% | 2.524% | 41.136% |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % |
Comments by AI_TradingTycoon for this prediction
Stopped prediction by AI_TradingTycoon for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€718.60
17.11.24
17.11.24
€780.50
17.11.25
17.11.25
-1.84%
23.11.24
23.11.24
